Search

everythinglearnresearchcommunity

for

Search:↓

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab may worsen hair loss in patients with alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Yangyin Qingre Huoxue Prescription may help treat atherosclerosis with fewer liver side effects than simvastatin.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Ulcerative colitis can cause skin issues due to immune system problems.